Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

Lucid Diagnostics Inc. Common Stock (LUCD)

Surgical & Medical Instruments & Apparatus

https://www.luciddx.com

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease, also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

360 MADISON AVENUE, 25TH FLOOR
NEW YORK, NY

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

10/14/2021

Market Cap

44,817,344

Shares Outstanding

44,670,000

Weighted SO

42,879,864

Total Employees

N/A

Upcoming Earnings

06/20/2025

Similar Tickers

NARI --.--%

XAIR --.--%

PAVMZ --.--%

CLPT --.--%

OSA --.--%

LIVN --.--%

ELMD --.--%

KIDS --.--%

SRDX --.--%

Beta

1.4540

Last Div

0.0000

Range

0.63-1.721

Chg

-0.0049

Avg Vol

139627

Mkt Cap

44817344

Exch

NASDAQ

Country

US

Phone

212 949 4319

DCF Diff

1.7725

DCF

-0.8820

Div Yield

0.0000

P/S

11.7940

EV Multiple

-0.7505

P/FV

2.5046

Div Yield %

0.0000

P/E

-0.8578

PEG

-0.0455

Payout

0.0000

Current Ratio

1.7489

Quick Ratio

1.6709

Cash Ratio

1.5594

DSO

15.3684

DIO

58.9106

Op Cycle

74.2791

DPO

42.6937

CCC

31.5854

Gross Margin

-1.0316

Op Margin

-11.7276

Pretax Margin

-12.2776

Net Margin

-12.2776

Eff Tax Rate

-118.5892

ROA

-1.3677

ROE

-6.6370

ROCE

-2.4577

NI/EBT

1.0000

EBT/EBIT

1.0469

EBIT/Rev

-11.7276

Debt Ratio

63.4973

D/E

135.5582

LT Debt/Cap

0.9926

Total Debt/Cap

0.9927

Int Coverage

7.6467

CF/Debt

-0.0198

Equity Multi

2.1349

Rec Turnover

23.7500

Pay Turnover

8.5493

Inv Turnover

6.1958

FA Turnover

0.9298

Asset Turnover

0.1114

OCF/Share

-0.8889

FCF/Share

-0.8936

Cash/Share

0.5169

OCF/Sales

-11.2774

FCF/OCF

1.0053

CF Coverage

-0.0198

ST Coverage

-3.5463

CapEx Coverage

-189.6195

Div&CapEx Cov

-189.6195

P/BV

2.5046

P/B

2.5046

P/S

11.7940

P/E

-0.8578

P/FCF

-1.0403

P/OCF

-0.9339

P/CF

-0.9339

PEG

-0.0455

P/S

11.7940

EV Multiple

-0.7505

P/FV

2.5046

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation